News

A recent CNN Health report highlights the ongoing shortage of albuterol, noting STAQ’s partnership with the Children’s Hospital Association in helping children’s hospitals get ahead of the problem.

With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according to a recent article by The Washington Post.

Albuterol — one of the most essential medications for pediatric patients — has been facing a critical shortage since June 2002. In partnership with Children’s Hospital Colorado (CHC), STAQ has been able to supply and maintain continuous albuterol for children’s hospitals. STAQ is committed to getting pediatric hospitals through this respiratory season and helping to ensure a stable supply for future seasons. Read the full story for details.

Being able to make a positive impact on the critical Albuterol shortage is one of the reasons we got into this business. The “A” in STAQ stands for availability, after all.

The results of STAQ’s partnership with Angels for Change to address shortages of two critical medications for children are not going unnoticed. Watch CNN’s powerful story and/or read the article here.

As a direct result of STAQ’s partnership with Angels for Change, in just the first 6 months, more than 500,000 pediatric patients have had been protected from a shortage of Potassium Chloride (KCl) and 23.4% Sodium Chloride (NaCL). Read the full story.

As part of its partnership with Angels for Change, STAQ has been producing critically-needed medications for pediatric patients as part of a new program called projectPROTECT. Watch the full video (just under 7 minutes) now.